{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:55:00Z","timestamp":1761058500058},"reference-count":27,"publisher":"Frontline Medical Communications, Inc.","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.sder.2006.04.004","type":"journal-article","created":{"date-parts":[[2006,8,13]],"date-time":"2006-08-13T11:06:09Z","timestamp":1155467169000},"page":"91-93","source":"Crossref","is-referenced-by-count":28,"title":["Toxic Epidermal Necrolysis and Intravenous Immunoglobulin: A Review"],"prefix":"10.12788","volume":"25","author":[{"given":"Jennifer","family":"Trent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Halem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars E.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Kerdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2006.04.004_bib1","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of stevens johnson syndrome and toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2006.04.004_bib2","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2006.04.004_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.283.2.175","article-title":"Recent therapeutic advances in dermatology","volume":"283","author":"Lipper","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.sder.2006.04.004_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2005.11.012","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"6","author":"French","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.sder.2006.04.004_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clnical classification of cases of toxic epidermal necrolysis, Stevens Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal mecrolysis and Stevens Johnson syndrome","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archderm.1992.01680110060006","article-title":"Immunopathology of toxic epidermal ncrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells","volume":"128","author":"Villada","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib8","first-page":"459","article-title":"Soluble fractions of tumor necrosis factor-alpha, interleukin 6, and of their receptors in toxic epidermal necrolysis","volume":"1","author":"Paquet","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.sder.2006.04.004_bib9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.sder.2006.04.004_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of cd95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.sder.2006.04.004_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with high dose intravenous immunoglobulins","volume":"139","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archderm.140.7.890","article-title":"SCORTEN Accurately predicts mortality in patients with toxic epidermal necrolysis in the United States","volume":"140","author":"Trent","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","article-title":"Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN","volume":"139","author":"Trent","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunglobulin treatment for stevens johnson syndrome and toxic epidermal necrolysis","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000051702","article-title":"Toxic epidermal necrolysis treated with intravenous high dose immunoglobulins","volume":"203","author":"Stella","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2006.04.004_bib17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1542\/peds.112.6.1430","article-title":"Use of intravenous immunoglobulin in children with Stevens Johnson syndrome and toxic epidermal necrolysis","volume":"112","author":"Metry","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.sder.2006.04.004_bib18","first-page":"430","article-title":"High dose intravenous immunoglobulin for severe drug reactions","volume":"83","author":"Campione","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2006.04.004_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2002.127249","article-title":"Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children","volume":"47","author":"Tristani-Firouzi","year":"2002","journal-title":"JAAD"},{"key":"10.1016\/j.sder.2006.04.004_bib20","first-page":"2494","article-title":"Intravenous immunoglobulin therapy for children with Stevens Johnson syndrome","volume":"27","author":"Morici","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.sder.2006.04.004_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000070957","article-title":"Effect of high dose intravenous immunoglobulin Therapy in Stevens Johnson syndrome","volume":"207","author":"Prins","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2006.04.004_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-4632.2004.02048.x","article-title":"Prospective, noncomparative open study from kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis","volume":"43","author":"Al-Mutairi","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2006.04.004_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.BCR.0000105096.93526.27","article-title":"Toxic epidermal necrolysis","volume":"25","author":"Brown","year":"2004","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.sder.2006.04.004_bib24","unstructured":"Trent JT, Ma FC, Kerdel FA, et al: High dose intravenous immunoglobulin is effective and does increase survival in patients with toxic epidermal necrolysis: a pooled analysis. Expert Rev Dermatol, in press"},{"key":"10.1016\/j.sder.2006.04.004_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"JAAD"},{"key":"10.1016\/j.sder.2006.04.004_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.sder.2006.04.004_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.BCR.0000124746.33279.86","article-title":"Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis","volume":"25","author":"Shortt","year":"2004","journal-title":"J Burn Rehabil"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562906000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562906000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/08\/v25i2-Trent.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T15:09:41Z","timestamp":1616166581000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1085562906000320"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2006.04.004","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}